Cargando…

The safety of agomelatine in standard medical practice in depressed patients: A 26‐week international multicentre cohort study

OBJECTIVE: The present observational cohort study documented the safety of agomelatine in current medical practice in out‐patients suffering from major depressive disorder. METHOD: The 6‐month evolution of agomelatine‐treated patients was assessed with a focus on safety (emergent adverse events, liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorwood, Philip, Benichou, Jacques, Moore, Nicholas, Álvarez Martínez, Enric, Mertens, Joost, Aguglia, Eugenio, Figueira, Maria‐Luisa, Falkai, Peter, Olivier, Valérie, Wattez, Marine, Picarel‐Blanchot, Françoise, de Bodinat, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816263/ https://www.ncbi.nlm.nih.gov/pubmed/32976677 http://dx.doi.org/10.1002/hup.2759

Ejemplares similares

Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France
por: Gorwood, Philip, et al.
Publicado: (2020)

Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
por: Stein, Dan J., et al.
Publicado: (2021)

Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study
por: Chabriat, Hugues, et al.
Publicado: (2020)

Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors
por: Signorelli, Maria S, et al.
Publicado: (2014)

Prevalence of Autism Spectrum Disorder and Co-morbidities in Children and Adolescents: A Systematic Literature Review
por: Bougeard, Clémence, et al.
Publicado: (2021)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

Agomelatine versus Sertraline: An Observational, Open-labeled and 12 Weeks Follow-up Study on Efficacy and Tolerability
por: Akpınar, Esma, et al.
Publicado: (2016)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014)

Agomelatine Efficacy in the Night Eating Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

Agomelatine: relief ensured at each and every stage of depression
por: Möller, Hans-Jurgen
Publicado: (2010)

A systematic review of agomelatine-induced liver injury
por: Freiesleben, Silka Dawn, et al.
Publicado: (2015)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders
por: Savino, Rosa, et al.
Publicado: (2023)

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
por: Li, Zhe, et al.
Publicado: (2023)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
por: Taylor, David, et al.
Publicado: (2014)

Successful Treatment with Agomelatine in NES: A Series of Five Cases
por: Milano, W., et al.
Publicado: (2013)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model
por: Inanir, Sema, et al.
Publicado: (2015)

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
por: Gahr, Maximilian
Publicado: (2014)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Publicado: (2014)

Novel Conformationally Constrained Analogues of Agomelatine as New Melatoninergic Ligands
por: Rami, Marouan, et al.
Publicado: (2012)

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2020)

Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2021)

Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice
por: Martin, Vincent, et al.
Publicado: (2017)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Publicado: (2013)

The effect of agomelatine and melatonin on sleep-related eating: a case report
por: Zapp, Angela Alexandra, et al.
Publicado: (2017)

Agomelatine Attenuates Isoflurane-Induced Inflammation and Damage in Brain Endothelial Cells
por: Cheng, Fang, et al.
Publicado: (2020)

Agomelatine Softens Depressive-Like Behavior through the Regulation of Autophagy and Apoptosis
por: Chen, Fengpei, et al.
Publicado: (2021)

Suspected Agomelatine-induced restless legs syndrome: a case report
por: Abdul Karim, Mustafa, et al.
Publicado: (2021)

The Effects of Agomelatine Treatment on Lipopolysaccharide-Induced Septic Lung Injuries in Rats
por: Köse, Duygu, et al.
Publicado: (2021)

Agomelatine prevents angiotensin II-induced endothelial and mononuclear cell adhesion
por: Hong, Najiao, et al.
Publicado: (2021)

Agomelatine, Ketamine and Vortioxetine Attenuate Energy Cell Metabolism—In Vitro Study
por: Ľupták, Matej, et al.
Publicado: (2022)

Agomelatine's antiglycoxidative action—In vitro and in silico research and systematic literature review
por: Nesterowicz, Miłosz, et al.
Publicado: (2023)

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
por: Fornaro, Michele, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6qv5f8cfti66nkusoam4q15c5c